Malignant Hemangiopericytoma in the Pelvic Cavity Successfully Treated by Combined-Modality Therapy: Report of a Case

Torigoe, Takayuki; Higure, Aiichiro; Hirata, Keiji; Nagata, Naoki; Itoh, Hideaki

doi:10.1007/s10595-002-2505-0

Cited by 11 publications

(10 citation statements)

References 18 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other pharmaceutical agents such as pazopanib, a tyrosine-kinase inhibitor, have exhibited clinical efficacy and the potential for management of metastatic hemangiopericytomas; however more studies still need to be conducted [ 20 ]. Reports regarding radiation therapy on the other hand have been inconsistent [ 16 , 21 – 24 ]. Our case was managed surgically with complete resection of the primary tumor and each of the two successive recurrences.…”

Section: Discussionmentioning

confidence: 99%

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Winer

Rasool

2016

Case Reports in Obstetrics and Gynecology

View full text Add to dashboard Cite

Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report.

show abstract

Section: Discussionmentioning

confidence: 99%

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Winer

Rasool

2016

Case Reports in Obstetrics and Gynecology

View full text Add to dashboard Cite

show abstract

“…In essence, if the time interval between the primary lesion and the liver metastatic disease is prolonged, major hepatectomy is justified in young individuals. In case of liver recurrence, re-resection combined with TAE is highly recommended, due to the hypervascular nature of the tumor [ 20 ].…”

Section: Discussionmentioning

confidence: 99%

Multidisciplinary Approach to Hepatic Metastases of Intracranial Hemangiopericytoma: A Case Report and Review of the Literature

Manatakis

Delis

Ptohis

et al. 2015

Case Reports in Oncological Medicine

View full text Add to dashboard Cite

Hemangiopericytoma is a rare primary tumor originating from Zimmerman's pericytes, with significant metastatic potential. Hepatic metastatic disease requires an aggressive approach by a multidisciplinary team of dedicated oncology specialists, to prolong survival in selected patients. We report on a patient with recurrent hepatic metastases of grade II intracranial hemangiopericytoma 5 years after initial treatment, managed by a stepwise combination of liver resection, radiofrequency ablation, and transarterial embolization. Although metastatic disease implies hematogenous dissemination, long-term survival after liver resection has been reported and major hepatectomies are justified in patients with adequate local control. Liver resections combined with transarterial embolization are highly recommended, due to hypervascularity of the tumor.

show abstract

“…The first one is arterial embolisation through Seldinger technique. There are well suceeded cases of hepatic artery embolisarion which reduced tumor size allowing curative resection [8]. Portal vein embolisarion induces vicarious hypertrophy of the future liver remnant permitting resection in primarily unresectable patients due to the small liver remnant expected.…”

Section: Discussionmentioning

confidence: 99%

hepatic metastasis of omental hemangiopericytoma:case report

Bugalia¹,

Salvi²,

Saxena³

et al. 2015

Int J of Biomed & Adv Res

View full text Add to dashboard Cite

Hemangiopericytoma (HPC) is a rare tumor that arises from the pericytes of Zimmermann. HPCs have a characteristic clinical feature the rate of recurrence which is as high as 52% of cases mostly in the lungs, liver, and regional lymph nodes and which necessitates long-term follow-up after resection of the primary tumor. Complete surgical removal is the treatment of choice for primary tumor local recurrence and solitary metastasis. The liver is an unusual location to the primary HPC but has been described as one of the most common site of distal metastases besides the bones and lungs. We present a case of a 55 year old man who was known case of an isolated omental HPC treated with excision of the omental mass 6 year back which recurred solely to the liver. The tumor occupied almost the entire left lobe with 9 x 7x 8 cm of diameter. The patient was submitted to uneventful uncomplicated left hepatectomy. In cases of inoperable recurrence or metastasis palliative chemotherapy is indicated though there is currently no approved chemotherapy regimen. Even though HPC is a well known neoplasm its incidence is very low. This article describes a case and addresses questions regarding diagnosis prognosis and treatment of this rare event.

show abstract

Malignant Hemangiopericytoma in the Pelvic Cavity Successfully Treated by Combined-Modality Therapy: Report of a Case

Cited by 11 publications

References 18 publications

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Multidisciplinary Approach to Hepatic Metastases of Intracranial Hemangiopericytoma: A Case Report and Review of the Literature

hepatic metastasis of omental hemangiopericytoma:case report

Contact Info

Product

Resources

About